Perbedaan DFI Retail Nusantara Tbk. dan UBC Medical Indonesia Tbk.: DFI Retail Nusantara Tbk. diperdagangkan di Rp330 (kapitalisasi pasar 1,36 T, volume 24 jam 298 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: DFI Retail Nusantara Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 298 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HERO | LABS | |
|---|---|---|
Kapitalisasi Pasar | 1,36 T | 584,6 M |
Volume | 298 rb | 817,3 rb |
Lot | 2,98 rb | 8,17 rb |
Perputaran | 98,02 jt | 120,01 jt |
Harga Rata-rata | 328,94 | 146,84 |
Nilai Transaksi | 98,02 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 330 | 146 |
Volume Ekuilibrium Indikatif | 40 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
The company began its commercial operations in August 1972. Hero is Indonesia’s largest supermarket chain with a network of 66 supermarkets, consisting of 44 stores in Greater Jakarta and 22 stores in major regional cities. Supermarket operations account for about 90% of sales complemented by an array of retail formats including convenience stores, mini markets, and pharmacies. The company’s mission is to be the leading modern food retailer in Indonesia in terms of sales and profits, targeting the middle to upper income consumer segments where buying power is greatest. As the economy begins to gather strength, HERO has relatively aggressive expansion plans drawing upon its established brand, a reputation for fresh quality foods, friendly experienced staff, best service, a leading position in category and space management and efficient centralized distribution infrastructure. In 1998 the acquisition of a 32% effective interest in Hero by Dairy Farm International contributed significant international experience and expertise to the local knowledge and insight of Hero’s management as well as recognition of the potential of Indonesia as one of the most attractive growth markets in South East Asia over the medium long term.
Selengkapnya di halaman HERO →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →